Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota

被引:385
作者
Elson, CO
Cong, Y
McCracken, VJ
Dimmitt, RA
Lorenz, RG
Weaver, CT
机构
[1] Univ Alabama Birmingham, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Pediat, Div Neonatol, Birmingham, AL 35294 USA
关键词
D O I
10.1111/j.0105-2896.2005.00291.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There are now many experimental models of inflammatory bowel disease (IBD), most of which are due to induced mutations in mice that result in an impaired homeostasis with the intestinal microbiota. These models can be clustered into several broad categories that, in turn, define the crucial cellular and molecular mechanisms of host microbial interactions in the intestine. The first of these components is innate immunity defined broadly to include both myeloid and epithelial cell mechanisms. A second component is the effector response of the adaptive immune system, which, in most instances, comprises the CD4(+) T cell and its relevant cytokines. The third component is regulation, which can involve multiple cell types, but again particularly involves CD4(+) T cells. Severe impairment of a single component can result in disease, but many models demonstrate milder defects in more than one component. The same is true for both spontaneous models of IBD, C3H/HeJBir and SAMPI/Yit mice. The thesis is advanced that 'multiple hits' or defects in these interacting components is required for IBD to occur in both mouse and human.
引用
收藏
页码:260 / 276
页数:17
相关论文
共 148 条
  • [31] Dianda L, 1997, AM J PATHOL, V150, P91
  • [32] Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated
    Diebold, RJ
    Eis, MJ
    Yin, MY
    Ormsby, I
    Boivin, GP
    Darrow, BJ
    Saffitz, JE
    Doetschman, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) : 12215 - 12219
  • [33] DEXTRAN SULFATE SODIUM-INDUCED COLITIS OCCURS IN SEVERE COMBINED IMMUNODEFICIENT MICE
    DIELEMAN, LA
    RIDWAN, BU
    TENNYSON, GS
    BEAGLEY, KW
    BUCY, RP
    ELSON, CO
    [J]. GASTROENTEROLOGY, 1994, 107 (06) : 1643 - 1652
  • [34] Selective expression of detoxifying glutathione transferases in mouse colon: effect of experimental colitis and the presence of bacteria
    Edalat, M
    Mannervik, B
    Axelsson, LG
    [J]. HISTOCHEMISTRY AND CELL BIOLOGY, 2004, 122 (02) : 151 - 159
  • [35] Ehrhardt RO, 1997, J IMMUNOL, V158, P566
  • [36] Crohn's disease: a defensin deficiency syndrome?
    Fellermann, K
    Wehkamp, J
    Herrlinger, KR
    Stange, EF
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (06) : 627 - 634
  • [37] Fort MM, 1998, J IMMUNOL, V161, P3256
  • [38] Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection
    Girardin, SE
    Boneca, IG
    Viala, J
    Chamaillard, M
    Labigne, A
    Thomas, G
    Philpott, DJ
    Sansonetti, PJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) : 8869 - 8872
  • [39] Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
    Gorelik, L
    Flavell, RA
    [J]. IMMUNITY, 2000, 12 (02) : 171 - 181
  • [40] NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?
    Grimm, MC
    Pavli, P
    [J]. GUT, 2004, 53 (11) : 1558 - 1560